[Antiviral activity of human recombinant gamma-interferon and recombinant hybrid protein of tumor necrosis factor-alpha-thymosin-alpha1 on models of herpes-virus and cytomegalovirus infection in vitro].
Barinskiĭ. I F IF; Alimbarova. L M LM; Platonova. A A AA; Shmelev. V A VA
Key Findings
- IFN‑gamma was more potent than the TNF‑alpha‑thymosin‑alpha‑1 hybrid at blocking HSV‑2 and CMV replication
- Both agents worked best when added before infection, showing preventive potential
- Combining IFN‑gamma with the hybrid gave a synergistic boost in antiviral effect
Practical Outcomes
- The study suggests thymosin‑alpha‑1‑based compounds might help fight certain viral infections, but only in a test‑tube setting. There’s no human dosage or safety data, so it’s not ready for self‑experimentation. Biohackers should view this as a preliminary clue rather than a ready‑to‑use protocol.
Summary
In lab tests, a hybrid protein that includes thymosin‑alpha‑1 (combined with TNF‑alpha) and interferon‑gamma can slow down herpes‑simplex‑2 and cytomegalovirus growth in human fibroblast cells, especially when given before the virus hits the cells. The effect isn’t a direct virus‑killing action, and the results are only from cell cultures, not people.
Abstract
The conducted studies showed a certain efficiency of gene-engineering preparation of IFN-gamma and TNF-T in virus infections caused by herpes simplex virus 2 (HSV-2) and cytomegalovirus (CMV) in cell cultures of human embryo fibroblast (HEF). The drugs have no viricidal action. IFN-gamma, when used according to the treatment scheme in vitro, proved to be more effective versus TMF-T both in HSV-2 and in CMV. It inhibited significantly the HSV-2 reproduction within the dilution range of 1:50 to 1:500. It was also effective, when used in CMV, within the dilution range of 1:5000 and lower, whereas TNF-T was effective within the range of 1:500 and lower as well as in 0.1 multiple infection. A significantly higher effect was ensured when the drugs were used for prevention. In HSV-2, IFN-gamma inhibited the virus reproduction, like in the treatment scheme, within the dilution range of 1:50 to 1:500, whereas TNF-T was effective in the range of 1:50. In CMV, the drugs' effect, when used for prevention, was similar to that observed in the treatment scheme. The highest inhibition values were registered for HSV-2, when it was used 24 hours before infection (IFN-gamma--2.25 Ig, dilution range of 1:50; TNF-2--1.0 Ig, dilution range of 1:50). IFN-gamma and TNF-2 exert a synergic action on different stages of virus reproduction. A reliable additive effect was ensured in prevention made 4 hour before infection by IFN-gamma and TNF-T only in experimental CMV infection.
Study Information
pubmed
2004